Epigallocatechin-3-gallate (EGCG), the major polyphenolic compound in green tea, has attracted attention for its therapeutic potential in CML through its inhibitory action on BCR-ABL and related oncogenic pathways. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.